夏冰，主治醫(yī)師，醫(yī)學(xué)碩士 教育背景： 2003.9—2010.9哈爾濱醫(yī)科大學(xué)臨床醫(yī)學(xué)七年制 社會職務(wù)： 抗癌協(xié)會會員 專業(yè)特長： 擅長各類急慢性白血病、惡性淋巴瘤、多發(fā)性骨髓瘤、骨髓增生異常綜合征(MDS)等疾病的診治。在臨床工作中注重規(guī)范化診療和實踐經(jīng)驗。 學(xué)術(shù)成就： 承擔(dān)天津市腫瘤醫(yī)院院級課題一項，參與自然科學(xué)基金，天津市自然科學(xué)基金等多項科研課題。發(fā)表SCI文章及核心期刊文章十余篇。 發(fā)表文章： 1. 夏冰，郭青，趙丹丹，田晨，張翼鷟，吳曉雄。骨髓增生異常綜合征中骨髓CD34+、CD34-細(xì)胞凋亡和增殖的實驗研究。天津醫(yī)科大學(xué)學(xué)報2012;18(3):285-288。 2. 夏冰，郭青，趙丹丹，趙海豐，韓曉蘋，王卉，吳曉雄，張翼鷟。骨髓增生異常綜合征患者骨髓CD34+和CD34-細(xì)胞凋亡與增殖的實驗研究及對生存的影響。實驗血液學(xué)2012;20(6):1392-1397。 3. 夏冰，郭青，趙偉鵬，王曉芳，王亞非，張翼鷟，張連郁。原發(fā)腸道的髓細(xì)胞肉瘤二例報道及文獻復(fù)習(xí)。2012; 33(10): 869-871。 4. 夏冰，郭青，趙偉鵬，郭姍琦，田晨，張翼鷟。c-Myc在骨髓基質(zhì)細(xì)胞介導(dǎo)的急性髓細(xì)胞白血病耐藥中作用。中華醫(yī)學(xué)雜志2013; 93(22): 1746 -1749。 5.李曉武，夏冰，郭青，晉鑫，于泳，趙智剛，王曉芳，王亞非，張翼鷟。103例胃黏膜相關(guān)淋巴組織淋巴瘤患者的臨床特點和預(yù)后分析。 6. Bing Xia Xiaowu Li Le Zhang Qing Guo Xin Jin ShanqiGuo Eduardo M. Sotomayor Yizhuo Zhang. BTK inhibitor PCI-32765 targets endogenous and microenvironment-mediated B-cell receptor signaling to supresslymphom cell growth and is highly synergistic with Bortezmib against non-Hodgkin B-cell lymphomas. (ASH Annual Meeting Abstract) Blood 2012; 120: Abstract 4721. 7. Zhang Y Zhao D Zhao H Wu X Zhao W Wang Y Xia B Da W.Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis. Medical Oncology. 2012; 29(4):2359-2363. 8. Xin Jin Fang Li ShanqiGuo Bing Xia Ling Zhang Yizhuo Zhang. Arsenic trioxide-induced apoptosis is associated with induction of SHP-1 in human cutaneous T cell lymphoma.(ASH Annual Meeting Abstracts)Blood 2012;120: Abstract 4716. 9. 12.Guo Qing Xia Bing. The role of CXCR4/STAT3/miRNAs in the microenvironment-mediated drug resistance in AML. 2012The first "Chinese Journal of Hematology" Annual Meeting. 10. Li X Xia B Guo S Zhan Z Zhang L Zhao D Wu X Zhang Y. A retrospective ysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components. Ann Hematol. 2013;92(6):807-815。 11. Yizhuo Zhang Qing Guo Dandan Zhao Haifeng Zhao Xiaoxiong Wu Weipeng Zhao Yafei Wang Bing Xia Wanming Da. Expression of CXCR4 is an independent prognostic factor for overall survival and relapse-free survival in patients with myelodysplastic syndrome .Medical oncology 2013;30(1):341. 12. Zhang Y Guo Q Zhao H Zhao D Wu X Zhao W Wang Y Xia B Da W.Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome. Medical Oncology. 2013; 30(1):341-346.